RT Journal Article
SR Electronic
T1 33 Blood-based tumor mutation burden (bTMB) predicts response to immune checkpoint blockade-based combination therapy (ICBC) in advanced non-small cell lung cancer (NSCLC): a real-world (RW) analysis
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A38
OP A38
DO 10.1136/jitc-2023-SITC2023.0033
VO 11
IS Suppl 1
A1 Gordon, Sean
A1 Pellini, Bruna
A1 Barnett, Reagan
A1 Liao, Jiemin
A1 Quinn, Katie
A1 Wienke, Sara
A1 Drusbosky, Leylah
A1 Zhang, Nicole
A1 Lefterova, Martina
A1 Lawrence, Lauren
A1 Kiedrowski, Lesli
A1 Eppler, Ross
A1 Odegaard, Justin
A1 Chuang, Han-Yu
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A38.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.